Articles tagged with 'Resorbable Magnesium Scaffold' | BIOTRONIK

BIOTRONIK - Archive (Resorbable Magnesium Scaffold)

2022
20
September
2022
| 15:41 Europe/Amsterdam
BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster session at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2022, principal investigator Prof. Dr. Johan Bennett presented the recent findings ...
Read more
20
September
2022
| 15:29 Europe/Amsterdam
In the “TCT Innovation” session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator, presented the new BIOMAG-I study results at the Transcatheter Cardiovascular Therapeutics (TCT) 2022. The multi-center study assesses the angiographic, ...
Read more
01
March
2022
| 09:27 Europe/Amsterdam
BIOTRONIK today announced final enrollment in the BIOMAG-I clinical trial1 by Prof. Michael Haude, Germany, the study’s coordinating clinical investigator and the principal investigator Prof. Javier Escaned, Spain. The prospective single-arm study as...
Read more
2021
08
November
2021
| 09:09 Europe/Amsterdam
Superiority of the Magmaris® sirolimus-eluting bioresorbable magnesium scaffold with regard to probable or definite scaffold thrombosis compared to a historical control group of Absorb scaffold data was demonstrated for the first time in a prospectiv...
Read more